mRNA |
Irinotecan |
gCSI |
pan-cancer |
AAC |
0.087 |
0.1 |
mRNA |
BRD8899 |
CTRPv2 |
pan-cancer |
AAC |
-0.06 |
0.1 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.055 |
0.1 |
mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
0.084 |
0.1 |
mRNA |
IU1 |
CTRPv2 |
pan-cancer |
AAC |
0.061 |
0.1 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.045 |
0.1 |
mRNA |
BRD-A94377914 |
CTRPv2 |
pan-cancer |
AAC |
-0.07 |
0.1 |
mRNA |
AZD-7545 |
CTRPv2 |
pan-cancer |
AAC |
0.057 |
0.1 |
mRNA |
cyanoquinoline 11 |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.1 |
mRNA |
TG-101348 |
CTRPv2 |
pan-cancer |
AAC |
-0.052 |
0.1 |